期刊文献+

中药肝毒性吡咯里西啶生物碱的质量控制研究进展 被引量:9

Research progress on quality control of hepatotoxic pyrrolizidine alkaloids in traditional Chinese medicine
原文传递
导出
摘要 吡咯里西啶生物碱在多种药用植物中普遍存在,现有证据表明其可引起不可逆的肝细胞损伤,具有较强的肝毒性,属于内源性毒性物质。近年来对肝毒性吡咯里西啶生物碱的质量研究有较多报道,但现行的大多数中药药品标准中并没有对该类毒性成分进行限量规定和风险提示,用药存在一定安全隐患。本文汇总了现行药材标准收录的可能含有肝毒性吡咯里西啶生物碱的品种及其含有的吡咯里西啶生物碱成分,归纳了常用的分析方法和存在的问题,并提出相关建议,为中药中该类成分的质量监管提供参考。 Pyrrolizidine alkaloids are common endogenous substances in plants,which can cause irreversible liver cell damage and have strong hepatotoxicity.In recent years,there have been many studies on the quality control of pyrrolizidine alkaloids,but there are few restrictions on such components in the current quality standards of traditional Chinese medicine,which indicates that there is a certain safety risk of medicine.This paper summarizes the varieties of pyrrolizidine alkaloids that may contain hepatotoxic pyrrolizidine alkaloids and the components of pyrrolizidine alkaloids contained in the current standards of Chinese medicine.It also summarizes the frequentlyused analysis methods and existing problems,and puts forward relevant suggestions for the quality regulation of such components in Chinese medicine.
作者 昝珂 蒋黄卉 金红宇 马双成 赵磊 孙艳涛 ZAN Ke;JIANG Huang-hui;JIN Hong-yu;MA Shuang-cheng;ZHAO Lei;SUN Yan-tao(National Institutes for Food and Drug Control,Beijing 100050,China;Chemistry of Jilin Normal University College,Siping 136000,China;Siping Institute for Food and Drug Control,Siping 136000,China)
出处 《药物分析杂志》 CAS CSCD 北大核心 2021年第4期572-578,共7页 Chinese Journal of Pharmaceutical Analysis
基金 科技部重大新药创制(2018ZX09303-024,2018ZX09735-006)。
关键词 中药 吡咯里西啶生物碱 质量控制 肝毒性 研究进展 监管对策 traditional Chinese medicines pyrrolizidine alkaloids quality control hepatotoxicity research progress regulatory strategy
  • 相关文献

参考文献12

二级参考文献166

共引文献170

同被引文献220

引证文献9

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部